Myelodysplastic Syndrome
📧 Sign up to get email alerts when something new happens for Myelodysplastic Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-06-06Clinical Trial Update: Dose-Ranging Study of Telintra® Tablets + Revlimid® in Patients With Non-Deletion (5q) Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS) [Phase 1]
This Phase 1 dose-ranging trial evaluated Telintra in combination with Revlimid in patients with non-deletion (5q) low- to intermediate-1 ri…
-
FDA approval · 2013-05-06FDA Approved: VIDAZA — Supplemental Application (Celgene Corporation)
The FDA approved a Celgene-supplied supplemental application for Vidaza (azacitidine), updating the drug's labeling and/or indications.
-
CLINICAL_TRIALS trial_result · 2013-04-10Clinical Trial Update: Study of New RIC Regimen of BuFlu in Older and/or Intolerable Patients
A clinical trial evaluating a new reduced-intensity conditioning regimen of busulfan/fludarabine in older and/or intolerant patients with le…
-
CLINICAL_TRIALS trial_result · 2013-04-09Clinical Trial Update: Deferoxamine for Iron Overload Before Allogeneic Stem Cell Transplantation [NA]
This clinical trial evaluated deferoxamine to manage iron overload before allogeneic stem cell transplantation in patients with acute myeloi…
-
CLINICAL_TRIALS trial_result · 2013-03-14Clinical Trial Update: Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies [Phase 3]
Phase 3 study evaluating methotrexate or pentostatin for graft-versus-host disease prophylaxis in risk-adapted allogeneic bone marrow transp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-03-12Clinical Trial Update: Decitabine for Myelodysplastic Syndromes and Acute Myeloid Leukemia Before Allogeneic Hematopoietic Cell Transplantation [Phase 4]
A Phase 4 clinical trial is evaluating decitabine given before allogeneic hematopoietic cell transplantation in patients with higher-risk my…
-
CLINICAL_TRIALS trial_result · 2013-03-08Clinical Trial Update: Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia and High-risk Myelodysplastic Syndrome [Phase 2]
Phase 2 trial evaluating decitabine in combination with gemtuzumab ozogamicin in adults with acute myeloid leukemia or high-risk myelodyspla…
-
CLINICAL_TRIALS trial_result · 2013-03-06Clinical Trial Update: Thymoglobulin and Cyclosporine in Patients With Aplastic Anemia or Myelodysplastic Syndrome [Phase 2]
Phase 2 clinical trial evaluating thymoglobulin in combination with cyclosporine in patients with aplastic anemia or myelodysplastic syndrom…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Observational Study of Iron Overload in Stem Cell Transplantation
This clinical trial update notes the completion of an observational study on iron overload in stem cell transplantation involving patients w…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Collection and Banking of Leukemia Cells MDS/AML [NA]
A completed clinical trial focusing on the collection and banking of leukemia cells in patients with myelodysplastic syndrome and acute myel…
-
CLINICAL_TRIALS trial_result · 2013-01-28Clinical Trial Update: Cephalon Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndrome [Phase 2]
Phase 2 trial evaluating a combination of decitabine, arsenic trioxide, and ascorbic acid for myelodysplastic syndrome has completed with re…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial Therapy [Phase 1, Phase 2]
This clinical trial update reports on a completed Phase 1/2 study of liposomal daunorubicin combined with SU5416 for hematologic cancers tha…
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial update describing a conditioning regimen of melphalan, fludarabine, and alemtuzumab followed by peripheral stem cell …
-
CLINICAL_TRIALS research · 2012-12-04Clinical Trial Update: Safety Study of Anti LewisY Chimeric Antigen Receptor in Myeloma, Acute Myeloid Leukemia or Myelodysplastic Syndrome [Phase 1]
A Phase 1 safety study evaluating an anti-LewisY chimeric antigen receptor therapy in patients with multiple myeloma, acute myeloid leukemia…
-
CLINICAL_TRIALS trial_result · 2012-10-19Clinical Trial Update: Bendamustine in Acute Leukemia and MDS [Phase 1, Phase 2]
Phase 1/2 trial of bendamustine in acute leukemia and myelodysplastic syndromes was terminated with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-10-11Clinical Trial Update: Phase II Research Study of Arsenic Trioxide (Trisenox) in Patients With Myelodysplastic Syndrome (MDS) [Phase 2]
A Phase II clinical trial evaluating arsenic trioxide (Trisenox) in patients with myelodysplastic syndrome was terminated.
-
CLINICAL_TRIALS trial_result · 2012-09-25Clinical Trial Update: Safety And Efficacy Of Azacitidine, and Lenalidomide In Higher Risk Myelodysplastic Syndrome [Phase 2]
Phase 2 clinical trial update assessing the safety and efficacy of azacitidine in combination with lenalidomide in patients with higher-risk…
-
CLINICAL_TRIALS trial_result · 2012-09-06Clinical Trial Update: Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain [Phase 3]
Phase 3 clinical trial evaluating an opioid titration order sheet versus standard care for cancer-related pain; the study is completed with …
-
CLINICAL_TRIALS trial_result · 2012-08-20Clinical Trial Update: Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies [Phase 2]
Phase 2 hematopoietic cell transplantation trial in pediatric patients with hematologic malignancies has completed and results have been pos…
-
CLINICAL_TRIALS trial_result · 2012-08-02Clinical Trial Update: Effectiveness of Protected Environment Rooms for AML and MDS
Clinical trial update on the effectiveness of protected environment rooms for Acute Myeloid Leukemia and Myelodysplastic Syndrome; the study…
-
CLINICAL_TRIALS trial_result · 2012-08-01Clinical Trial Update: Symptom-Related Cytokines in Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Patients
This update reports a completed clinical trial studying symptom-related cytokines in patients with acute myeloid leukemia and myelodysplasti…
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: Azacitidine Maintenance Therapy After Allogeneic Bone Marrow Transplantation (Allo BMT) [Phase 1]
This report notes the completion of a Phase 1 clinical trial evaluating azacitidine as maintenance therapy after allogeneic bone marrow tran…
-
CLINICAL_TRIALS withdrawal · 2012-07-30Clinical Trial Update: NOV-002 in Myelodysplastic Syndrome (MDS) [Phase 2]
Phase 2 trial of NOV-002 in myelodysplastic syndrome has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-07-27Clinical Trial Update: 2 Arm Study of Clofarabine IV in MDS Patients [Phase 2]
Phase 2 trial evaluating intravenous Clofarabine in patients with myelodysplastic syndrome and leukemia has completed, with results posted i…
-
CLINICAL_TRIALS trial_result · 2012-07-26Clinical Trial Update: Safety Study of IL-7 in Recipients of a Hemopoietic Stem Cell Transplant Peripheral Blood Stem Cell Transplant [Phase 1]
Phase 1 safety study of interleukin-7 in recipients of a hematopoietic stem cell transplant (peripheral blood) has completed.